Investor Relations

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.

In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.


DIRECTOR INTERVIEWS- Proactive Investors, with Christine Corrado

At Biotech Showcase, Jan. 15, 2020


INNOVATORS with Jane King – interviewing CEO Glenn Mattes
& Dr. Bill Williams - Professor at Univ. of Texas – Austin

At the NASDAQ Market Site, Nov. 20, 2019


Copyright West LLC. Minimum 15 minutes delayed.

Press Releases